The Valley Desk

NCT06634589 · Interventional trial

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions B-cell Lymphoma, B-cell Malignancy, Refractory Cancer, Relapsed Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov